Recent Finacing
Recent Raise
PentixaPharm is a joint venture developing a CXCR4-targeted theranostic radiopharmaceutical pair—PentixaFor ([68Ga] PET imaging) and PentixaTher (alpha- or beta-labeled endoradiotherapy)—with ongoing clinical trials in hematologic and CNS malignancies.
